Medroxyprogesterone acetate (Mpa) enhances hiv-1 accumulation and release in primary cervical epithelial cells by inhibiting lysosomal activity

Xiangxu Jia, Qiujia Shao, Ahsen R. Chaudhry, Ballington L. Kinlock, Michael G. Izban, Hong Ying Zhang, Fernando Villalta, James E.K. Hildreth, Bindong Liu

Research output: Contribution to journalArticlepeer-review

Abstract

Medroxyprogesterone acetate (MPA) is one of the most widely used contraceptives in the world. Epidemiologic studies have uncovered a possible link between the use of MPA and an increased risk of HIV-1 transmission. However, the understanding of the mechanism is still limited. Our previous publication demonstrated that the lysosomal activity in human vaginal epithelial cells attenuated the trafficking of viral particles during HIV-1 transcytosis. In this study, we show that treating human primary cervical epithelial cells with MPA led to a reduction in lysosomal activity. This reduction caused an increase in the intracellular HIV-1 accumulation and, consequently, an increase in viral release. Our study uncovers a novel mechanism by which MPA enhances HIV-1 release in primary cervical epithelial cells, thus providing vital information for HIV intervention and prevention.

Original languageEnglish (US)
Article number1192
JournalPathogens
Volume10
Issue number9
DOIs
StatePublished - Sep 2021
Externally publishedYes

Keywords

  • HIV-1
  • Lysosome activity
  • Medroxyprogesterone acetate
  • MPA
  • Transmission

ASJC Scopus subject areas

  • Immunology and Allergy
  • Molecular Biology
  • Immunology and Microbiology(all)
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Medroxyprogesterone acetate (Mpa) enhances hiv-1 accumulation and release in primary cervical epithelial cells by inhibiting lysosomal activity'. Together they form a unique fingerprint.

Cite this